AnalystsRudy Li
Rudy Li's Stock Forecasts

Analyst Ranking
Top 2%
#89 out of 5342 analysts
Average Return
+112.55%
Win Rate
80%32 out of 40
Risk vs Reward
Poor
Good

Rudy Li's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+787.56%$38.09$338.07
2025-05-07 -
2026-05-06
Strong Buy
Alto Neuroscience IncANRO
+575.06%$4.01$27.07
2025-09-29 -
2026-07-31
Strong Buy
Praxis Precision Medicines IncPRAX
+428.61%$55.96$295.81
2025-07-29 -
2026-07-28
Strong Buy
Definium Therapeutics IncDFTX
+415.64%$8.44$43.52
2025-08-01 -
2026-07-31
Strong Buy
Stoke Therapeutics IncSTOK
+275.54%$8.26$31.02
2025-03-19 -
2026-03-18
Strong Buy

Rudy Li's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Uniqure NvQURE
1Buy$65.00+48.98%Upgrades
3 days ago
Lb Pharmaceuticals IncLBRX
1Buy$45.00+12.28%Initiates Coverage On
a month ago
Centessa Pharmaceuticals PLCCNTA
5Buy$40.00-1.23%Initiates Coverage On
5 months ago
Alkermes PLCALKS
1Buy$45.00-8.14%Initiates Coverage On
5 months ago
Axsome Therapeutics IncAXSM
1Buy$230.00+5.51%Initiates Coverage On
5 months ago
Xenon Pharmaceuticals IncXENE
5Buy$60.00-4.26%Initiates Coverage On
5 months ago
Stoke Therapeutics IncSTOK
5Buy$40.00+38.60%Initiates Coverage On
5 months ago
Praxis Precision Medicines IncPRAX
4Buy$500.00+62.43%Initiates Coverage On
5 months ago
Neurocrine Biosciences IncNBIX
1Buy$160.00-4.08%Initiates Coverage On
5 months ago
Definium Therapeutics IncDFTX
5Buy$25.00-42.56%Initiates Coverage On
5 months ago
Acadia Pharmaceuticals IncACAD
1Buy$33.00+27.56%Initiates Coverage On
5 months ago
Bright Minds Biosciences IncDRUG
3Strong Buy$80.00N/AMaintains
7 months ago
Immunic IncIMUX
1Strong Buy$30.00+114.75%Initiates Coverage On
10 months ago
Alto Neuroscience IncANRO
1Strong Buy$15.00-44.59%Initiates Coverage On
10 months ago
Reviva Pharmaceuticals Holdings IncRVPH
1Strong Buy$40.00+12,021.21%Initiates Coverage On
10 months ago
Prothena Corp Public Ltd CoPRTA
7Strong Buy$18.00+121.67%Maintains
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.